These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31086604)

  • 1. Long non-coding RNA BLACAT1 promotes the proliferation and invasion of glioma cells via Wnt/β-catenin signaling.
    Li X; Qi S; Ma D; Fan J; Wang J
    Exp Ther Med; 2019 Jun; 17(6):4703-4708. PubMed ID: 31086604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
    Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
    Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
    Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA BLACAT1 promotes cell proliferation and invasion in human cervical cancer.
    Shan D; Shang Y; Hu T
    Oncol Lett; 2018 Mar; 15(3):3490-3495. PubMed ID: 29456724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlocking the Therapeutic Potential of LncRNA
    Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
    Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of long non-coding RNA BLACAT1 predicts aggressive clinicopathologic characteristics and poor prognosis of glioma.
    Zhang X; Wei X; Liu J; Yang J; Jin P
    Medicine (Baltimore); 2021 Mar; 100(11):e20722. PubMed ID: 33725920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SUMO1P3 promotes glioma progression via the Wnt/β-catenin pathway.
    Lou JY; Luo J; Yang SC; Ding GF; Liao W; Zhou RX; Qiu CZ; Chen JM
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9571-9580. PubMed ID: 33015800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway.
    He P; Xiong G; Guo W; Jiang G; Li Y; Li H
    Oncol Lett; 2020 Oct; 20(4):97. PubMed ID: 32831916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA BLACAT1 expedites osteosarcoma cell proliferation, migration and invasion via up-regulating SOX12 through miR-608.
    Chen X; Cui Y; Ma Y
    J Bone Oncol; 2020 Dec; 25():100314. PubMed ID: 33005563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BLACAT1 is negatively associated with prognosis in patients with NSCLC and inhibits cell progression, metastasis and epithelial-mesenchymal transition through down-regulating Wnt/β-catenin signaling pathway.
    Xu R; Cao XR; Zhang BQ; Wang JL; Wang L; Sun WQ
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6217-6225. PubMed ID: 31364123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling.
    Wang H; Sheng ZG; Dai LZ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1600-1609. PubMed ID: 30840283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA BLACAT1 regulates VASP expression via binding to miR-605-3p and promotes giloma development.
    Liu N; Hu G; Wang H; Wang Y; Guo Z
    J Cell Physiol; 2019 Dec; 234(12):22144-22152. PubMed ID: 31093978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways.
    Li S; Mao L; Zhao F; Yan J; Song G; Luo Q; Li Z
    J Cancer; 2021; 12(14):4341-4354. PubMed ID: 34093834
    [No Abstract]   [Full Text] [Related]  

  • 19. Overexpression of the long non-coding RNA
    Bu C; Wang B; Zhang D; Mao Z; Pu C
    Transl Cancer Res; 2019 Feb; 8(1):35-43. PubMed ID: 35116731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion.
    Hou M; Wu N; Yao L
    Cancer Cell Int; 2021 Jan; 21(1):36. PubMed ID: 33422081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.